Kallisio develops patient‑specific precision solutions for oncology, beginning with Stentra™—an FDA‑ and CE‑cleared custom 3D‑printed immobilization device that fits head and neck cancer patients with sub‑millimeter accuracy. The device integrates into existing radiation therapy workflows, reducing simulation setup time by up to 2–3 hours per patient and minimizing side effects caused by generic equipment. Kallisio’s platform combines digital imaging, data‑driven design, and scalable manufacturing to create individualized treatments across cancer care.
Funding
Funding not disclosed
Founders
Product
Problem
Standard immobilization devices for head and neck radiation therapy are generic and cannot accommodate each patient’s unique oral anatomy, leading to imprecise targeting, increased side effects such as mucositis, treatment interruptions, and longer setup times.
Solution
Kallisio offers Stentra™, an FDA‑cleared and CE‑marked custom 3D‑printed intraoral immobilization device that fits each patient’s anatomy with sub‑millimeter precision. The workflow begins with a 15‑minute intraoral scan, after which a patient‑specific device is digitally designed, 3D printed in medical‑grade resin, and delivered within 72 hours, ready for the first treatment session. The device securely positions the tongue and jaw, reduces radiation exposure to healthy tissue, and is reusable across all treatment fractions with validated reprocessing. Stentra integrates into existing radiation oncology workflows without additional hardware or software, is HIPAA‑compliant, and eligible for CPT reimbursement, thereby improving treatment accuracy, reducing side effects, and saving 2–3 hours of simulation setup per patient.
Target Audience
Primary customers are radiation oncology departments and head‑and‑neck cancer treatment centers seeking precise, patient‑specific immobilization solutions for radiotherapy.
Features
- Patient‑specific design from a 15‑minute intraoral scan (STL, DICOM, optical formats supported)
- Sub‑millimeter fit for precise tongue and jaw positioning
- Configurable tongue displacement (depress, elevate, left/right lateralisation) to protect healthy tissue
- Delivered in 72 hours, ready before the first radiotherapy session
- Reusable across all treatment sessions with validated cleaning and dedicated storage container
- No impact on radiation beam; low‑density, radiopaque material compatible with standard planning
- CPT‑reimbursable under code 77334; end‑to‑end HIPAA‑compliant workflow